Jump to main content
Jump to site search

Issue 6, 2017
Previous Article Next Article

A metabolomic study on high-risk stroke patients determines low levels of serum lysine metabolites: a retrospective cohort study

Author affiliations

Abstract

Identifying changes in serum metabolites during cerebral ischemia is an important approach for early diagnosis of thrombotic stroke. Herein, we highlight novel biomarkers for early diagnosis of patients at high risk of thrombotic stroke using high resolution metabolomics (HRM). In this retrospective cohort study, serum samples obtained from patients at risk of thrombotic stroke (n  =  62) and non-risk individuals (n  =  348) were tested using HRM, coupled with LC-MS/MS, to discriminate between metabolic profiles of control and stroke risk patients. Multivariate analysis and orthogonal partial least square-discriminant analysis (OPLS-DA) were performed to determine the top 5% metabolites within 95% group identities, followed by filtering with p-value <0.05 and annotating significant metabolites using a Metlin database. Mapping identified features from Kyoto Encyclopedia of Genes and Genomes (KEGG) and Mummichog resulted in 341 significant features based on OPLS-DA with p-value <0.05. Among these 341 features, nine discriminated the thrombotic stroke risk group from the control group: low levels of N6-acetyl-L-lysine, 5-aminopentanoate, cadaverine, 2-oxoglutarate, nicotinamide, L-valine, S-(2-methylpropionyl)-dihydrolipoamide-E and ubiquinone, and elevated levels of homocysteine sulfinic acid. Further analysis showed that these metabolite biomarkers are specifically related to stroke occurrence, and unrelated to other factors such as diabetes or smoking. Lower levels of lysine catabolites in thrombotic stroke risk patients, as compared to the control, supports targeting these compounds as novel biomarkers for early and non-invasive detection of a thrombotic stroke.

Graphical abstract: A metabolomic study on high-risk stroke patients determines low levels of serum lysine metabolites: a retrospective cohort study

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Oct 2016, accepted on 03 Apr 2017 and first published on 07 Apr 2017


Article type: Paper
DOI: 10.1039/C6MB00732E
Citation: Mol. BioSyst., 2017,13, 1109-1120
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    A metabolomic study on high-risk stroke patients determines low levels of serum lysine metabolites: a retrospective cohort study

    Y. Lee, A. Khan, S. Hong, S. H. Jee and Y. H. Park, Mol. BioSyst., 2017, 13, 1109
    DOI: 10.1039/C6MB00732E

    This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements